Restricted accessResearch articleFirst published online 2020-05
Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages
Support of human immunodeficiency virus (HIV) and tuberculosis (TB) testing and treatment supported by President's Emergency Plan for AIDS Relief (PEPFAR) in Africa requires immense quantities of tests and medications. We sought to use central pharmacy supply data of Mozambique's rural Zambézia Province (2017 population ≈5.11 million persons; ≈12.6% adult HIV prevalence in 2016) to examine shortages, stockouts, and trends in availability. Using stock surveillance for 60 weeks in 2014–2015, we assessed availability of 36 medications [4 classes: adult antiretroviral (ARV) medications, pediatric ARVs, anti-TB medications, and antibiotics] and diagnostic test kits (2 rapid tests for HIV; 1 each for malaria and syphilis). We contrasted these to 2018–2019 data. We modeled pharmacy data using ordinal logistic regression, characterizing weekly product availability in four categories: good, adequate, shortage, or complete stockout. We found 166 (7.7%) stockouts and 150 (6.9%) shortages among 2,160 weekly records. Earlier calendar time was associated with reduced medication supplies (p < .001). Certain medication/test kit classes were associated with reduced supply (p < .001). We found an interaction between time and medication class on the odds of reduced supply (p < .001). Pediatric ARVs had a 17.4 (95% confidence interval: 8.8–34.4) times higher odds of reduced medication supply compared with adult ARVs at study midpoint. Trends comparing the first and last weeks showed adult ARVs having 67% and pediatric having 71% lower odds of reduced supplies. Only adult ARV shortages improved amid growing demand. Data from 2018 to 2019 suggest continuing inventory management challenges. Monitoring of drug (especially pediatric) and test kit shortages is vital to ensure quality improvement to guarantee adequate supplies to enable patients and care providers to achieve sustained viral suppression. A central Mozambican drug repository in the nation's second largest Province continues to experience drug and rapid test kit stockouts.
Get full access to this article
View all access options for this article.
References
1.
MoriAT, OwenyaJ: Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: A cross-sectional study. J Pharm Policy Pract, 2014; 7:3.
2.
BamL, McLarenZM, CoetzeeE, von LeipzigKH: Reducing stock-outs of essential tuberculosis medicines: A system dynamics modelling approach to supply chain management. Health Policy Plan, 2017; 32:1127–1134.
3.
JatauB, AvongY, OgundahunsiO, et al.: Procurement and supply management system for MDR-TB in Nigeria: Are the early warning targets for drug stock outs and over stock of drugs being achieved?. PLoS One, 2015; 10:e0128500.
4.
MastersSH, BursteinR, DeCensoB, et al.: Pharmaceutical availability across levels of care: Evidence from facility surveys in Ghana, Kenya, and Uganda. PLoS One, 2014; 9:e114762.
5.
DesaleA, TayeB, BelayG, NigatuA: Assessment of laboratory logistics management information system practice for HIV/AIDS and tuberculosis laboratory commodities in selected public health facilities in Addis Ababa, Ethiopia. Pan Afr Med J, 2013; 15:46.
6.
MalatiC, RosenfeldJ, MowafyS, RittmillerT, KuritskyJ, CrowleyJ: Dealing with large-scale supply lines when introducing new regimens. Curr Opin HIV AIDS, 2017; 12:408–413.
7.
LeungNH, ChenA, YadavP, GallienJ: The impact of inventory management on stock-outs of essential drugs in Sub-Saharan Africa: Secondary analysis of a field experiment in Zambia. PLoS One, 2016; 11:e0156026.
8.
AnselmiL, LagardeM, HansonK: Health service availability and health seeking behaviour in resource poor settings: Evidence from Mozambique. Health Econ Rev, 2015; 5:62.
9.
LuansC, CardietI, RogéP, et al.: Causes and consequences of anti-infective drug stock-outs. Med Mal Infect, 2014; 44:470–477.
10.
MillerML, KarwaR, SchellhaseEM, et al.: Meeting the needs of underserved patients in western Kenya by creating the next generation of global health pharmacists. Am J Pharm Educ, 2016; 80:22.
11.
Mikkelsen-LopezI, TediosiF, AbdallahG, et al.Beyond antimalarial stock-outs: Implications of health provider compliance on out-of-pocket expenditure during care-seeking for fever in South East Tanzania. BMC Health Serv Res, 2013; 13:444.
12.
AnokbonggoWW, Ogwal-OkengJW, ObuaC, AupontO, Ross-DegnanD: Impact of decentralization on health services in Uganda: A look at facility utilization, prescribing and availability of essential drugs. East Afr Med J, 2004; 81(Suppl):S2–S7.
13.
MoriartyK, GenbergB, NormanB, ReeceR: The effect of antiretroviral stock-outs on medication adherence among patients living with HIV in Ghana: A qualitative study. J Assoc Nurses AIDS Care, 2018; 2:231–240.
14.
VermandereH, GalleA, GriffinS, et al.: The impact of facility audits, evaluation reports and incentives on motivation and supply management among family planning service providers: An interventional study in two districts in Maputo Province, Mozambique. BMC Health Serv Res, 2017; 17:313.
15.
HodesR, PriceI, BunganeN, ToskaE, CluverL: How front-line healthcare workers respond to stock-outs of essential medicines in the Eastern Cape Province of South Africa. S Afr Med J, 2017; 107:738–740.
16.
ChukwuOA, EzeanochikwaVN, EyaBE: Supply chain management of health commodities for reducing global disease burden. Res Social Adm Pharm, 2017; 13:871–874.
17.
HarrellF: Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. Basel: Springer International Publishing, Switzerland, 2015.
18.
VermundSH, BlevinsM, MoonTD, et al.: Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: Need for program quality improvement and community engagement. PLoS One, 2014; 9:e110116.
19.
VermundSH, SidatM, WeilLF, TiqueJA, MoonTD, CiampaPJ: Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS, 2012; 26:1303–1310.
20.
SharmaA, ChiliadeP, ReyesEM, ThomasKK, CollensSR, MoralesJR: Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: Stakeholder perspectives. Glob Health Action, 2013; 6:22571.
21.
WagenaarBH, GimbelS, HoekR, et al.: Stock-outs of essential health products in Mozambique—Longitudinal analyses from 2011 to 2013. Trop Med Int Health, 2014; 19:791–801.
22.
WagenaarBH, StergachisA, RaoD, et al.: The availability of essential medicines for mental healthcare in Sofala, Mozambique. Glob Health Action, 2015; 8:27942.
23.
The Office of theU.S. Global AIDS Coordinator. PEPFAR 3.0: Controlling the epidemic: Delivering on the promise of an AIDS-free generation. (Department of State, ed.) Office of Global Publishing Solutions, Washington, DC. Available at www.pepfar.gov/documents/organization/234744.pdf, accessed May25, 2019.
24.
EdwardsLJ, MoisésA, NzarambaM, et al.: Implementation of a health management mentoring program: Year-1 evaluation of its impact on health system strengthening in Zambezia Province, Mozambique. Int J Health Policy Manag, 2015; 4:353–361.
25.
Kälvemark SporrongS, TraulsenJM, Damene KabtimerW, et al.: Developing and sustaining human resources in the health supply chain in Ethiopia: Barriers and enablers. Rural Remote Health, 2016; 16:3613.
26.
FattiG, MonteithL, ShaikhN, KappE, FosterN, GrimwoodA: Implementation and operational research: A comparison of two task-shifting models of pharmaceutical care in antiretroviral treatment programs in South Africa. J Acquir Immune Defic Syndr, 2016; 71:e107–e113.
27.
LubingaSJ, JennyAM, Larsen-CooperE, et al.: Impact of pharmacy worker training and deployment on access to essential medicines and health outcomes in Malawi: Protocol for a cluster quasi-experimental evaluation. Implement Sci, 2014; 9:156.
28.
SpisakC, MorganL, EichlerR, RosenJ, SerumagaB, WangA: Results-based financing in Mozambique's Central Medical Store: A review after 1 year. Glob Health Sci Pract, 2016; 4:165–177.
29.
WagenaarBH, GimbelS, HoekR, et al.: Effects of a health information system data quality intervention on concordance in Mozambique: Time-series analyses from 2009–2012. Popul Health Metr, 2015; 13:9.
30.
HasselbackL, CrawfordJ, ChalucoT, RajagopalS, ProsserW, WatsonN: Rapid diagnostic test supply chain and consumption study in Cabo Delgado, Mozambique: Estimating stock shortages and identifying drivers of stock-outs. Malar J, 2014; 13:295.
31.
GeelhoedD, LafortY, Chissale É, CandrinhoB, DegommeO: Integrated maternal and child health services in Mozambique: Structural health system limitations overshadow its effect on follow-up of HIV-exposed infants. BMC Health Serv Res, 2013; 13:207.
32.
HardingR, SimmsV, PenfoldS, et al.: Availability of essential drugs for managing HIV-related pain and symptoms within 120 PEPFAR-funded health facilities in East Africa: A cross-sectional survey with onsite verification. Palliat Med, 2014; 26:293–301.
33.
BerhanemeskelE, BeedemariamG, FentaTG: HIV/AIDS related commodities supply chain management in public health facilities of Addis Ababa, Ethiopia: A cross-sectional survey. J Pharm Policy Pract, 2016; 9:11.
34.
WindischR, WaiswaP, NeuhannF, ScheibeF, de SavignyD: Scaling up antiretroviral therapy in Uganda: Using supply chain management to appraise health systems strengthening. Global Health, 2011; 7:25.
35.
MagadzireBP, WardK, LengHMJ, SandersD: Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa. S Afr Med J, 2017; 107:581–584.
36.
CarloL, BakkenS, MamykinaL, KodieR, KanterA: Towards a tool for malaria supply chain management improvement in rural Ghana. Stud Health Technol Inform, 2015; 216:1006.
37.
HasselbackL, DickoM, ViadroC, NdourS, NdaoO, WessonJ: Understanding and addressing contraceptive stockouts to increase family planning access and uptake in Senegal. BMC Health Serv Res, 2017; 17:373.
38.
MalikM, HassaliMA, ShafieAA, HussainA: Why hospital pharmacists have failed to manage antimalarial drugs stock-outs in Pakistan? A qualitative insight. Malar Res Treat, 2013; 2013:342843.
39.
GithinjiS, KigenS, MemusiD, et al.: Reducing stock-outs of life saving malaria commodities using mobile phone text-messaging: SMS for life study in Kenya. PLoS One, 2013; 8:e54066.
40.
Mikkelsen-LopezI, ShangoW, BarringtonJ, ZieglerR, SmithT: The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: The case of Tanzania. Malaria J, 2014; 13:181.
41.
AlbaS, HetzelMW, GoodmanC, et al.: Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-a provider perspective. Malaria J, 2010; 9:164.
42.
ChukwuaniCM, OlugbojiA, UgbeneE: Improving access to essential drugs for rural communities in Nigeria: The Bamako initiative re-visited. Pharm World Sci, 2006; 28:91–95.
43.
BarringtonJ, Wereko-BrobbyO, WardP, MwafongoW, KungulweS: SMS for Life: A pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology. Malar J, 2010; 9:298.
44.
PrinjaS, BahugunaP, TripathyJP, KumarR: Availability of medicines in public sector health facilities of two North Indian States. BMC Pharmacol Toxicol, 2015; 16:43.
45.
LufesiNN, AndrewM, AursnesI: Deficient supplies of drugs for life threatening diseases in an African community. BMC Health Serv Res, 2007; 7:86.
46.
RathishD, PremarathnaI, JayathilakeT, et al.: Availability of essential medicines in selected public, primary and secondary health care institutions of a rural Sri Lankan district: A spot survey. BMC Health Serv Res, 2017; 17:11.
47.
RamosMI, CubillasJJ, FeitoFR: Improvement of the prediction of drugs demand using spatial data mining tools. J Med Systems, 2016; 40:6.
48.
ArneyL, YadavP, MillerR, WilkersonT: Strategic contracting practices to improve procurement of health commodities. Glob Health Sci Pract, 2014; 2:295–306.
49.
Mikkelsen-LopezI, CowleyP, KasaleH, MbuyaC, ReidG, de SavignyD: Essential medicines in Tanzania: Does the new delivery system improve supply and accountability?. Health Syst (Basingstoke), 2014; 3:74–81.
50.
GroseJ, RichardsonJ: Strategies to identify future shortages due to interruptions in the health care procurement supply chain and their impact on health services: A method from the English National Health Service. J Health Serv Res Policy, 2014; 19:19–26.
51.
OkoliU, OduenyiC, OnwudinjoN, et al.: Engaging communities in commodity stock monitoring using telecommunication technology in primary health care facilities in rural Nigeria. Health Serv Res Manag Epidemiol, 2015; 2:2333392815609143.
52.
ManjiI, ManyaraSM, JakaitB, et al.: The Revolving Fund Pharmacy Model: Backing up the Ministry of Health supply chain in western Kenya. Int J Pharm Pract, 2016; 24:358–366.
53.
BinyarukaP, BorghiJ: Improving quality of care through payment for performance: Examining effects on the availability and stock-out of essential medical commodities in Tanzania. Trop Med Int Health, 2017; 22:92–102.
54.
MarteiYM, GroverS, BilkerWB, et al.: Impact of essential medicine stock outs on cancer therapy delivery in a resource-limited setting. J Glob Oncol, 2019; 5:1–11.
55.
KuupielD, TlouB, BawontuoV, DrainPK, Mashamba-ThompsonTP: Poor supply chain management and stock-outs of point-of-care diagnostic tests in Upper East Region's primary healthcare clinics, Ghana. PLoS One, 2019; 14:e0211498.
56.
ZakumumpaH, KiweewaFM, KhuluzaF, KitutuFE: “The number of clients is increasing but the supplies are reducing”: Provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited settings: A qualitative study from Uganda. BMC Health Serv Res, 2019; 19:312.
57.
HwangB, ShroufiA, GilsT, et al.: Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey. PLoS One, 2019; 14:e0212405.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
